Health Technology · Pharmaceuticals: Major · NSE: PGHL · data 2026-10-09

Procter & Gamble Health Ltd.

Health check: Strong (7.5/10 on quality, valuation vs sector, growth and momentum).

Open full analysis — chart, results, balance sheet, red flags →

Key figures

Price

₹5,205

Market cap

₹8,561 cr

P/E

26.4

P/B

16.5

ROE

61.6%

ROCE

75.7%

Debt / equity

0.02

Dividend yield

3.01%

1-year return

-16.5%

52-week high

₹6,975

52-week low

₹4,707

Operating margin

30.8%

Growth

Revenue (last 12 months)	₹1,408 cr
Net profit (last 12 months)	₹327 cr
Sales growth, 3 years (yearly)	8.2%
Profit growth, 3 years (yearly)	19.3%

Similar companies

Blue Jet Healthcare Limited (BLUEJET) · Sanofi Consumer Healthcare India Limited (SANOFICONR) · Suven Life Sciences Limited (SUVEN) · Aarti Pharmalabs Limited (AARTIPHARM) · Morepen Laboratories Limited (MOREPENLAB)

The full analysis has the price chart, every quarterly result with YoY/QoQ growth, the balance sheet and cash flow with an accounting red-flag check, shareholding quarter by quarter with big investors, news, filings and bulk/block deals.

Open PGHL in NSE Scanner →